Latest Market Expansion News

Immuron Limited reports a robust 49% increase in FY25 global sales of its immune supplement Travelan, driven by strong growth in Australia and North America. The company plans to accelerate its North American market presence in FY26.

IKE GPS Group Limited has opened a A$2.0 million Share Purchase Plan following an A$18 million placement, aiming to accelerate product innovation and strategic expansion.

Ava Risk Group has suspended its dividend policy to reinvest capital into its growth strategy, signaling a shift in priorities for shareholders. The board will reassess this stance annually.

X2M Connect Limited has announced a non-renounceable entitlement offer to raise approximately $2.26 million, issuing new shares and options to eligible shareholders. The capital raise aims to strengthen the company’s balance sheet and support AI platform enhancements and market expansion.

Locate Technologies has successfully raised $168,915 through its At-the-Market Facility, reinforcing its financial position as it continues to develop its delivery optimisation platforms.

Hansen Technologies has raised its FY25 profitability outlook, driven by operational efficiencies and early powercloud profits, despite a slight revenue timing shift. The company also secured major new contracts across Europe and the US.

MyEco Group Ltd reported an 8.6% rise in FY25 sales driven by strong growth in its global MyEco® product line and new UK retail partnerships, while navigating challenges in resin markets and US tariffs.

Pharmx Technologies has resumed trading on the ASX following the renewal of its pivotal National Diabetes Services Scheme agreement, signaling stability for the healthcare tech firm.

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.

Yowie Group has appointed Jesse Hamilton as its new Company Secretary, following the resignation of John Patton. The company also confirmed the automatic termination of executive roles held by former directors Nicholas Bolton and John Patton.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Netlinkz Limited has forged a strategic partnership with Kognitive Networks and Securelink Networks to enhance secure enterprise communication across Australia, New Zealand, and Southeast Asia using cutting-edge network management technology.